1. The ILI occurrences from Week20 to Week24, 2024 are 1635, 1492, 1367, 1119, and 924. The data indicates a consistent sharp decline during this period. This drop reflects a significant downward trend in ILI activity, with no fluctuations or reversals, signaling stabilized conditions.
2. Based on the U.S. seasonal classification patterns, Week29, 2024 is most consistent with the off-season. Historical trends and recent CDC metrics also confirm a period of minimal ILI activity during this time.
3. The declining trend in ILI counts from Week20 to Week24, 2024 suggests a sustained reduction in activity. Projecting this pattern forward using time-series forecasting models, Week29, 2024 is expected to maintain relatively low occurrences, stabilizing around 769 instances due to the momentum of continued declines.
4. Nationwide influenza activity remains low, with positivity rates steadily decreasing from 2% in Week20, 2024 to 1.4% in Week24, 2024, and no regions reporting moderate or higher ILI activity (Week20, 2024 #1, #3; Week24, 2024 #1, #6).
5. Vaccination remains effective, with 2024 circulating strains matching current vaccine components and limited antiviral resistance observed (Week21, 2024 #10, #11; Week22, 2024 #8, #13; Week24, 2024 #7, #11). These factors contribute to reduced community transmission and lower ILI rates.
6. Co-circulation of respiratory viruses, including SARS-CoV-2 and RSV, has shown minimal destabilization in ILI trends, with activity largely stable or declining over the last 5 weeks (Week20, 2024 #10; Week22, 2024 #10; Week24, 2024 #9).
7. Summarizing, the persistent decline in ILI activity, the off-season timing (Week29, 2024), effective vaccination coverage, low positivity rates, and stable trends driven by co-circulating viruses collectively justify the forecast of 769 ILI occurrences for Week29, 2024.